Successful autologous peripheral blood stem cell transplantation using thiotepa in a patient with systemic sclerosis and cardiac involvement

Tohoku Journal of Experimental Medicine

Volumn 209, Issue 1, 2006, Pages 61-67

  Komatsuda, Atsushi ^a   Kawabata, Yoshinari ^a   Horiuchi, Takahito ^a   Motegi, Mutsuhito ^a   Ozawa, Masatoyo ^a   Fujishima, Naohito ^a   Kume, Masaaki ^a   Hirokawa, Makoto ^a   Wakui, Hideki ^a   Yamaguchi, Akihiko ^b   Sawada, Ken Ichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Senboku Kumiai General Hospital   (Japan)

Author keywords

Autologous peripheral blood stem cell transplantation (PBSCT); Cardiotoxicity; Cyclophosphamide; Systemic sclerosis; Thiotepa

Indexed keywords

CD34 ANTIGEN; CILOSTAZOL; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; FUROSEMIDE; IMMUNOGLOBULIN G; PREDNISOLONE; THIOTEPA;

ADULT; ANTIBODY TITER; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; CARDIOTOXICITY; CASE REPORT; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REGIMEN; DRUG MEGADOSE; ECHOCARDIOGRAPHY; EDEMA; ELECTROCARDIOGRAPHY; HEART PALPITATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPOXEMIA; LABORATORY DIAGNOSIS; LOW DRUG DOSE; MALE; PERICARDIAL EFFUSION; SCORING SYSTEM; SIDE EFFECT; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS; WEIGHT GAIN;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; HEART DISEASES; HUMANS; MALE; MYELOABLATIVE AGONISTS; SCLERODERMA, SYSTEMIC; STEM CELL TRANSPLANTATION; THIOTEPA; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 33646195492     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.209.61     Document Type: Article

References (23)

1. Aversa, F., Terenzi, A., Carotti, A., Flicini, R., Jacucci, R., Zei, T., Latini, P., Aristei, C., Santucci, A., Martelli, M.P., Cunningham, I., Reisner, Y. & Martelli, M.F. (1999) Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia. J. Clin. Oncol., 17, 1545-1550.
2. Burt, R.K., Oyama, Y., Traynor, A., Quigley, K., Brush, M., Rodriguez, J. & Barr, W.G. (2003) Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring? Bone Marrow Transplant., 32, Suppl. 1, S65-S67.
3. Clements, P.J., Lachenbruch, P.A., Seibold, J.R., Zee, B., Steen, V.D., Brennan, P., Silman, A.J., Allegar, N., Varga, J. & Massa, M. (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J. Rheumatol., 20, 1892-1896.
4. Farge, D., Marolleau, J.P., Zohar,. S., Marjanovic, Z., Cabane, J., Mounier, N., Hachulla, E., Philippe, P., Sibilia, J., Rabian, C., Chevret, S. & Gluckman, E. (2002) Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study. Br. J. Haematol., 119, 726-739.
5. Farge, D., Passweg, J., van Laar, J.M., Marjanovic, Z., Besenthal, C., Finke, J., Peter, H.H., Breedveld, F.C., Fibbe, W.E., Black, C., Denton, C., Koetter, I., Locatelli, F., Martini, A., Schattenberg, A.V., van den Hoogen, F., van de Putte, L., Lanza, F., Arnold, R., Bacon, P.A., Bingham, S., Ciceri, F., Didier, B., Diez-Martin, J.L., Emery, P., Feremans, W., Hertenstein, B., Hiepe, F., Luosujarvi, R., Leon Lara, A., Marmont, A., Martinez, A.M., Pascual Cascon, H., Bocelli-Tyndall, C., Gluckman, E., Gratwohl, A. & Tyndall, A. (2004) Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann. Rheum. Dis., 63, 974-981.
6. Ferri, C., Valentini, G., Cozzi, F., Sebastiani, M., Michelassi, C., La Montagna, G., Bullo, A., Cazzato, M., Tirri, E., Storino, F., Giuggioli, D., Cuomo, G., Rosada, M., Bombardieri, S., Todesco, S. & Tirri, G. (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine, 81, 139-153.
7. Fujimaki, K., Maruta, A., Yoshida, M., Sakai, R., Tanabe, J., Koharazawa, H., Kodama, F., Asahina, S., Minamizawa, M., Matsuzaki, M., Fujisawa, S., Kanamori, H. & Ishigatsubo, Y. (2001) Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant., 27, 307-310.
8. Gharib, M.I. & Burnett, A.K. (2002) Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. Eur. J. Heart Fail., 4, 235-242.
9. Giorgetti, F., Minnucci, M.L., Santori, P., Ercoli, L., Rossi, M., Del Papa, M., Morico, G., Squadroni, P., Olivieri, A. & Centurioni, R. (2004) Autologous peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience. Reumatismo, 56, 51-56. (in Italian with English abstract)
10. Ioannidis, J.P., Vlachoyiannopoulos, P.G., Haidich, A.B., Medsger, T.A., Jr., Lucas, M., Michet, C.J., Kuwana, M., Yasuoka, H., van den Hoogen, F., Te Boome, L., van Laar, J.M., Verbeet, N.L., Matucci-Cerinic, M., Georgountzos, A. & Moutsopoulos, H.M. (2002) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am. J. Med., 118, 2-10.
11. Itoh, M., Iwai, K., Kotone-Miyahara, Y., Yamada, H., Ohno, H., Yamamoto, K., Tashima, M., Inoko, M., Nohara, R. & Uchiyama, T. (2004) Successful allogeneic bone marrow transplantation for acute myelogenous leukemia after drug-induced cardiomyopathy. Tohoku J. Exp. Med., 204, 85-91.
12. Janosik, D.L., Osborn, T.G., Moore, T.L., Shah, D.G., Kenney, R.G. & Zuckner, J. (1989) Heart disease in systemic sclerosis. Semin. Arthritis. Rheum., 19, 191-200.
13. Kawabata, Y., Hirokawa, M., Komatsuda, A. & Sawada, K. (2003) Clinical applications of CD34+ cell-selected peripheral blood stem cells. Ther. Apher. Dial., 7, 298-304.
14. McSweeney, P.A., Nash, R.A., Sullivan, K.M., Storek, J., Crofford, L.J., Dansey, R., Mayes, M.D., McDonagh, K.T., Nelson, J.L., Gooley, T.A., Holmberg, L.A., Chen, C.S., Wener, M.H., Ryan, K., Sunderhaus, J., Russell, K., Rambharose, J., Storb, R. & Furst, D.E. (2002) High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood, 100, 1602-1610.
15. Nishio, M., Nakao, S., Endo, T., Fujimoto, K., Takashima, H., Sakai, T., Bacigalupo, A., Koike, T. & Sawada, K. (2001) Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure. Bone Marrow Transplant., 28, 783-785.
16. Saccardi, R., Tyndall, A., Coghlan, G., Denton, C., Edan, G., Emdin, M., Farge, D., Fassas, A., Finke, J., Furst, D., Lassus, M., Mancardi, G., Miniati, I., Mini, E., Pagliai, F., Passweg, J., Pignone, A., van Laar, J.M., Bocelli-Tyndall, C. & Matucci-Cerinic, M. (2004) Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant., 34, 877-881.
17. Sakkas, L.I. & Platsoucas, C.D. (2004) Is systemic sclerosis an antigen-driven T cell disease? Arthritis. Rheum., 50, 1721-1733.
18. Scussel-Lonzetti, L., Joyal, F., Raynauld, J.P., Roussin, A., Rich, E., Goulet, J.R., Raymond, Y. & Senecal, J.L. (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine, 81, 154-167.
19. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis. Rheum., 23, 581-590.
20. Tang, W.H.W., Thomas, S., Kalaycio, M., Sobecks, R., Andresen, S., Jarvis, J., Rybicki, L., Pohlman, B., Francis, G.S. & Bolwell, B.J. (2004) Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction? Bone Marrow Transplant., 34, 603-607.
21. Tyndall, A. & Gratwohl, A. (1997) Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br. J. Pheumatol., 36, 390-392.
22. White, B., Moore, W.C., Wigley, F.M., Xiao, H.Q. & Wise, R.A. (2000) Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann. Intern. Med., 132, 947-954.
23. Wolff, S.N., Herzig, R.H., Fay, I.W., LeMaistre, C.F., Brown, R.A., Frei-Lahr, D., Stranjord, S., Giannone, L., Coccia, P. & Weick, J.L. (1990) High-dose N,N′,N_Pm-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies. Semin. Oncol., 17, Suppl. 3, 2-6.